Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2009Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synoviumDharmapatni, A.; Smith, M.; Findlay, D.; Holding, C.; Evdokiou, A.; Ahern, M.; Weedon, H.; Chen, P.; Screaton, G.; Xu, X.; Haynes, D.
2002Receptor activator NFκB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysisCrotti, T.; Smith, M.; Weedon, H.; Ahern, M.; Findlay, D.; Kraan, M.; Tak, P.; Haynes, D.
2003Receptor activator NF kB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitisCrotti, T.; Smith, M.; Hirsch, R.; Soukoulis, S.; Weedon, H.; Capone, M.; Ahern, M.; Haynes, D.
2008Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcomeHaynes, D.; Crotti, T.; Weedon, H.; Slavotinek, J.; Au, V.; Coleman, M.; Roberts-Thomson, P.; Ahern, M.; Smith, M.
2005Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosisWalker, J.; Stirling, J.; Beroukas, D.; Dharmapatni, A.; Haynes, D.; Smith, M.; Ahern, M.; Roberts-Thomson, P.
2009Pathogenic bone loss in rheumatoid arthritis: Mechanisms and therapeutic approachesCantley, M.; Smith, M.; Haynes, D.
2003Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: Quantification using color video image analysisCrotti, T.; Ahern, M.; Lange, K.; Weedon, H.; Coleman, M.; Roberts-Thomson, P.; Haynes, D.; Smith, M.